Search hospitals > Florida > Saint Petersburg
Meridien Research
Claim this profileSaint Petersburg, Florida 33709
Global Leader in Alzheimer's Disease
Conducts research for COVID-19
Conducts research for Depression
Conducts research for Major Depressive Disorder
Conducts research for Diabetes
115 reported clinical trials
1 medical researcher
Summary
Meridien Research is a medical facility located in Saint Petersburg, Florida. This center is recognized for care of Alzheimer's Disease, COVID-19, Depression, Major Depressive Disorder, Diabetes and other specialties. Meridien Research is involved with conducting 115 clinical trials across 97 conditions. There are 1 research doctors associated with this hospital, such as Jay Meyer.Top PIs
Clinical Trials running at Meridien Research
COVID-19
Coronavirus
Viral Infections
Viral Diseases
Flu
Infections
Respiratory Infection
Contagious Diseases
mRNA-1273.214 Vaccine
for COVID-19 in Children
This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in participants aged 6 months to <6 years, when administered as a primary series in SARS-CoV-2 vaccine-naïve participants (Part 1) and a single booster dose (BD) given to participants who previously received 2 doses of the mRNA-1273 vaccine as a primary series (Part 2); and will evaluate the safety and immunogenicity of the mRNA-1273.815 vaccine, when administered as a BD in participants aged 6 months to <6 years (Part 3) and when administered to SARS-CoV-2 vaccine-naïve participants aged 2 years to <5 years of age (Part 4).
Recruiting3 awards Phase 3
COVID-19 Vaccine
for Children
The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy children. The trial is divided into 5 individual studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies will receive study vaccine as a shot depending on what group they are in. Substudy A design: Phase 1 includes participants 6 months through less than 4 years 3 months of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naïve) and will receive 3 doses of study vaccine as their initial series, followed by a fourth dose of study vaccine. Phase 2/3 includes participants 6 months through less than 5 years of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naive) and will receive 1, 2, or 3 doses of study vaccine, depending on what group they are in. Substudy B design: includes participants 6 months through less than 5 years of age who have either received 2 or 3 prior doses of BNT162b2 and will receive study vaccine as their third or fourth dose. Substudy C design: Phase 1 includes participants 6 months through less than 5 years of age who have received 3 prior doses of BNT162b2 and will receive study vaccine as their fourth dose. Substudy D design: includes participants 5 through less than12 years of age who have received 2 or 3 prior doses of BNT162b2 and will receive study vaccine as their third or fourth dose. Substudy E design: includes participants 2 through less than 12 years of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naive) and will receive a single dose of study vaccine.
Recruiting1 award Phase 2 & 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Meridien Research?
Meridien Research is a medical facility located in Saint Petersburg, Florida. This center is recognized for care of Alzheimer's Disease, COVID-19, Depression, Major Depressive Disorder, Diabetes and other specialties. Meridien Research is involved with conducting 115 clinical trials across 97 conditions. There are 1 research doctors associated with this hospital, such as Jay Meyer.